Roivant Sciences Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ROIV Nasdaq 2830 roivant.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Roivant Sciences Ltd.

Roivant Soars 8% as Brepocitinib Delivers “Phenomenal Results” in Two Phase 3 Uveitis Trials - Oct 23rd, 2026 11:25 am
Roivant Sciences’ Brepocitinib Delivers Positive Phase III Uveitis Results - Oct 21st, 2026 9:04 am
Roivant Sciences stock surges on positive uveitis trial data - Oct 21st, 2026 7:09 am
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026 - Oct 21st, 2026 5:00 am
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026 - Oct 21st, 2026 5:00 am
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU) - Oct 21st, 2026 5:00 am
Roivant Sciences (ROIV) Stock Looks Fully Priced After A 393% Run - Oct 18th, 2026 6:20 pm
IMVT, ROIV Stocks Slide As Argenx Sjögren’s Trial Failure Hits Drug Class - Oct 8th, 2026 11:33 am
Roivant Sciences Targets LISRAYA Launch, Key Pipeline Readouts in Next 12 Months - Sep 28th, 2026 2:02 am
Roivant’s Lung Drug Clears Phase 2 Test: Is Another Major Pipeline Asset Emerging? - Sep 24th, 2026 11:02 am
Roivant’s Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Miss - Sep 23rd, 2026 6:12 am
Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus - Sep 23rd, 2026 5:00 am
Roivant (ROIV): $9 Billion Sales Potential Faces a Commercialization Test - Sep 22nd, 2026 4:27 am
What Is Roivant Sciences (ROIV) Signaling With Its Positive PH ILD Trial Data? - Sep 18th, 2026 5:15 am
Roivant Sciences Ltd. (ROIV)’s Pulmonary Hypertension Breakthrough Could Transform Its Growth Story - Sep 13th, 2026 3:45 am
Podcast: key readouts from ESC and ERS - Sep 10th, 2026 5:55 am
Company News for Sep 9, 2026 - Sep 9th, 2026 5:15 am
Why Did DELL, ROIV, SHEL Stocks Surge To 52-Week Highs Today? - Sep 8th, 2026 9:00 pm
Roivant (ROIV) Soars to All-Time High; Q2 Hedge Fund Holdings Surge 41% - Sep 8th, 2026 7:40 pm
Biotech Stocks, With 'Blowout' And 'Bull Case' Results, Rocket To Record Highs - Sep 8th, 2026 2:24 pm